Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Update for Option 2 and 3 Users

1. Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Update for Option 2 and 3 Users Joint Presentation by: Immunization Services Division National Center for Immunization and Respiratory Diseases and Division of Emergency Preparedness and Response National Center for Public Health Informatics Webinar Presentation to Public Health Project Areas October 17, 2007

2. Agenda • Background on Aggregate Reporting • Refresher and Update on Pilot Test • Checklist Items • Demonstration of CRA • Next Steps • Available Resources

3. Background • The National Strategy for Pandemic Influenza: Implementation Plan calls for monitoring of the appropriate use of a scarce pandemic influenza vaccine • To accomplish this, states/ project areas will track vaccine doses administered, collect and aggregate minimum data elements and transmit weekly to CDC • CDC’s CRA system was modified to provide three ways for states and partners to report vaccine doses administered

4. Background: Options for Aggregate Reporting to CDC • Option 1: For states and project areas collecting data via an existing immunization information system (IIS) or other application, technical specifications were developed for three different data exchange formats: flat file (pipe-delimited), XML file, HL 7 • Option 2: For states and project areas collecting data manually, an aggregate reporting screen was added to CDC’s CRA application to allow direct data entry via a web browser • Option 3: For states and project areas using CDC’s CRA application to collect patient level information, selected data elements will be automatically aggregated

5. Pandemic Influenza Doses Administered Pilot Reporting Event (PIDAPRE) • CDC and the project areas will test options during the influenza season • Evaluate project area capabilities to aggregate and send a subset of data • Evaluate CDC technical system capabilities to accept and report aggregate vaccine doses administered

6. Why is the Pilot Test Necessary ? • Operational Perspective • To assess the ability to collect and report vaccine doses administered data and to provide perspective on federal, project area, and clinic needs in order to scale-up for a pandemic situation • Technical Perspective • To assess the technical ability of systems to receive, aggregate, and return data, to identify and address system gaps and to test tooling options and security aspects for federal and state partners

7. Data Expected from the Project Area • Will include (required) • Age • 6 – 23 months • 2 – 18 years • 19 – 49 years • 50 – 64 years • 65+ years • Project Area ID • Date of Clinic(s)

8. Update on PIDAPRE • CDC and the project areas will test options during the influenza season • Pilot test November 1st – December 31st • We have received option choices from all 62 project areas (100%)

9. Project Area Option Choices 32 22 8 100% of Project Areas have submitted their reporting option choices, and over 50% of Project Areas have submitted testing dates.

10. Option Choices of states/ project areasfor the pilot test Chicago Option 1 American Samoa Option 2 NY City Marshall Islands Option 3 Guam DC Mariana Islands LA county Virgin Islands Palau Puerto Rico FS Micronesia

11. Check list for Option 2 *Full checklist available at www.cdc.gov/phin/cra

12. Check list for Option 3

13. Option 2 and 3 Progress To Date • Clinic Dates for Option 2 • 16 out of 32 Confirmed or have been received • Clinic Dates for Option 3 • 4 out of 8 Confirmed or have been received

14. Frequently Asked Questions • Can a project area choose one reporting option initially and then switch to another reporting option in the future? • Can a blanket digital certificate be issued to a project area? • Can participation in PIDAPRE be reported in PERFORMS? • Can we enter data before November 1st?

15. PIDAPRE Demonstration • Enter Aggregate Counts (Option 2) • Rapid Patient Data Entry (Option 3) • Generate Extract of Aggregate Data

16. Additional Resources • CRA Exchange (https://team.cdc.gov) • Interactive knowledge sharing forum • Access to additional resources • Training Material • User Guide • Recorded Demo • CRA web site (http://www.cdc.gov/phin/cra) • Copy of previous webinars and presentations • Pilot Test Resources • CRA Demo Site (http://crademo.cdc.gov)

17. Next Steps • Submit clinic dates to CDC CRA Point of Contact • Ensure all CRA users have a digital certificate (PHINTECH@cdc.gov) • Email CRAHelp@cdc.gov to access CRA Exchange • Access CRA Exchange to download CRA training material

18. Project Area Assistance

19. Points of Contact • PHIN Help Desk • Issuing Digital certificates • Getting access to CRA demonstration site • Problem solving Phone: (800) 532-9929 Email: PHINTECH@cdc.gov Office Hours: Mon. – Fri., 8:00 AM – 8:00 PM Eastern • CRA Information Center (CRAHelp@cdc.gov) • Getting access to CRA Exchange • General aggregate reporting questions and inquires

20. Questions?Questions may also be emailed to: CRAHelp@cdc.gov